List of Figures:
Figure 1. Research Method Flow Chart 12
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 15
Figure 3. North America Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031 17
Figure 4. North America Transcriptomics Market, 2021-2031, $ mn 20
Figure 5. Impact of COVID-19 on Business 23
Figure 6. Primary Drivers and Impact Factors of North America Transcriptomics Market 25
Figure 7. Primary Restraints and Impact Factors of North America Transcriptomics Market 30
Figure 8. Investment Opportunity Analysis 34
Figure 9. Porter’s Fiver Forces Analysis of North America Transcriptomics Market 37
Figure 10. Breakdown of North America Transcriptomics Market by Component, 2021-2031, % of Revenue 42
Figure 11. North America Addressable Market Cap in 2022-2031 by Component, Value ($ mn) and Share (%) 42
Figure 12. North America Transcriptomics Market by Component: Instruments, 2021-2031, $ mn 43
Figure 13. North America Transcriptomics Market by Component: Consumables, 2021-2031, $ mn 45
Figure 14. North America Transcriptomics Market by Component: Software, 2021-2031, $ mn 47
Figure 15. North America Transcriptomics Market by Component: Services, 2021-2031, $ mn 49
Figure 16. Breakdown of North America Transcriptomics Market by Technology, 2021-2031, % of Sales Revenue 51
Figure 17. North America Addressable Market Cap in 2022-2031 by Technology, Value ($ mn) and Share (%) 51
Figure 18. North America Transcriptomics Market by Technology: Polymerase Chain Reaction (PCR), 2021-2031, $ mn 52
Figure 19. North America Transcriptomics Market by Technology: Next-Generation Sequencing, 2021-2031, $ mn 54
Figure 20. North America Transcriptomics Market by Technology: Microarray, 2021-2031, $ mn 56
Figure 21. North America Transcriptomics Market by Technology: In-Situ Hybridization (ISH), 2021-2031, $ mn 58
Figure 22. North America Transcriptomics Market by Technology: Gene Regulation Technologies, 2021-2031, $ mn 60
Figure 23. North America Transcriptomics Market by Technology: Other Technologies, 2021-2031, $ mn 61
Figure 24. Breakdown of North America Transcriptomics Market by Application, 2021-2031, % of Sales Revenue 63
Figure 25. North America Addressable Market Cap in 2022-2031 by Application, Value ($ mn) and Share (%) 63
Figure 26. North America Transcriptomics Market by Application: Drug Discovery and Development, 2021-2031, $ mn 64
Figure 27. North America Transcriptomics Market by Application: Diagnostics, 2021-2031, $ mn 65
Figure 28. North America Transcriptomics Market by Application: Single Cell Analysis, 2021-2031, $ mn 66
Figure 29. North America Transcriptomics Market by Application: Gene Expression, 2021-2031, $ mn 67
Figure 30. North America Transcriptomics Market by Application: Cell Biology, 2021-2031, $ mn 68
Figure 31. North America Transcriptomics Market by Application: Other Applications, 2021-2031, $ mn 69
Figure 32. Breakdown of North America Transcriptomics Market by End User, 2021-2031, % of Revenue 71
Figure 33. North America Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%) 71
Figure 34. North America Transcriptomics Market by End User: Academic and Research Institutions, 2021-2031, $ mn 72
Figure 35. North America Transcriptomics Market by End User: Biotechnology and Biopharmaceutical Companies, 2021-2031, $ mn 73
Figure 36. North America Transcriptomics Market by End User: Contract Research Organizations (CROs), 2021-2031, $ mn 74
Figure 37. North America Transcriptomics Market by End User: Other End Users, 2021-2031, $ mn 75
Figure 38. Breakdown of North America Transcriptomics Market by Country, 2021 and 2031, % of Revenue 77
Figure 39. Contribution to North America 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 78
Figure 40. U.S. Transcriptomics Market, 2021-2031, $ mn 80
Figure 41. Canada Transcriptomics Market, 2021-2031, $ mn 82
Figure 42. Transcriptomics Market in Mexico, 2021-2031, $ mn 84
Figure 43. Growth Stage of North America Transcriptomics Industry over the Forecast Period 86
North America transcriptomics market is projected to grow by 10.3% annually in the forecast period and reach $6,124.0 million by 2031, driven by the surging demand for personalized medicine, the high demand for diagnostic of inflammatory diseases such as COVID-19, the decrease in the cost of sequencing, the rising application of next-generation sequencing and RNA sequencing in transcriptomics, and the advancement of products launches along with increasing R&D expenditure. Highlighted with 32 tables and 43 figures, this 114-page report “North America Transcriptomics Market 2021-2031 by Component (Instruments, Consumables, Software, Services), Technology (PCR, Next-Generation Sequencing, Microarray, ISH, Gene Regulation, Others), Application (Drug Discovery and Development, Diagnostics, Single Cell Analysis, Gene Expression, Cell Biology, Others), End User (Academic and Research Institutions, Biotech and Biopharma Companies, CROs, Others), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire North America transcriptomics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2019-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify North America transcriptomics market in every aspect of the classification from perspectives of Component, Technology, Application, End User, and Country. Based on Component, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Instruments • Consumables • Software • Services Based on Technology, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Polymerase Chain Reaction (PCR) • Next-Generation Sequencing • Microarray • In-Situ Hybridization (ISH) • Gene Regulation Technologies • Other Technologies By Application, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Drug Discovery and Development • Diagnostics • Single Cell Analysis • Gene Expression • Cell Biology • Other Applications By End User, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Academic and Research Institutions • Biotechnology and Biopharmaceutical Companies • Contract Research Organizations (CROs) • Other End Users Geographically, the following national/local markets are fully investigated: • U.S. • Canada • Mexico For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Component, Technology and Application over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Selected Key Players: 10x Genomics Agilent Technologies, Inc. ANGLE plc Becton, Dickinson and Company (BD) Bio-Rad Laboratories, Inc. BioSypder, Inc. Bio-Techne Cytiva F. Hoffmann-La Roche Ltd. Fluidigm Corporation GE Healthcare Illumina, Inc. Menarini Silicon Biosystems Merck & Co., Inc. NanoString Pacific Biosciences of California, Inc. PerkinElmer Inc. Promega Corporation Qiagen N. V. Takara Bio Inc. Thermo Fisher Scientific Inc. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Read More